Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8IFN | R9UQ53 | MERS-CoV spike trimer in complex with nanobody VHH-T148 | |
| 8IF4 | P54289 | Structure of human alpha-2/delta-1 without mirogabalin | |
| 8IF3 | P54289 | Structure of human alpha-2/delta-1 with mirogabalin | |
| 8IF2 | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
| 8IF2 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
| 8IDS | A0A2Z5WH92 | Crystal structure of Bacillus sp. AHU2216 GH13_31 Alpha-glucosidase E256Q/N258P in complex with maltotriose | |
| 8IDQ | A0A0B8MZ29 | Crystal structure of reducing-end xylose-releasing exoxylanase in GH30 from Talaromyces cellulolyticus with xylose | |
| 8IDP | A0A0B8MZ29 | Crystal structure of reducing-end xylose-releasing exoxylanase in GH30 from Talaromyces cellulolyticus | |
| 8IDO | R9UQ53 | Crystal structure of nanobody VHH-T148 with MERS-CoV RBD | |
| 8IDO | 8IDO | Crystal structure of nanobody VHH-T148 with MERS-CoV RBD | |
| 8IDN | P0DTC2 | Cryo-EM structure of RBD/E77-Fab complex | |
| 8IDN | 8IDN | Cryo-EM structure of RBD/E77-Fab complex | |
| 8IDM | 8IDM | Crystal structure of nanobody VHH-227 with nanobody VHH-T71 and MERS-CoV RBD | |
| 8IDM | R9UQ53 | Crystal structure of nanobody VHH-227 with nanobody VHH-T71 and MERS-CoV RBD | |
| 8IDI | 8IDI | Crystal structure of nanobody VHH-T71 with MERS-CoV RBD | |
| 8IDI | R9UQ53 | Crystal structure of nanobody VHH-T71 with MERS-CoV RBD | |
| 8IDA | P08195 | Overall structure of the LAT1-4F2hc bound with tyrosine | |
| 8IDA | Q01650 | Overall structure of the LAT1-4F2hc bound with tyrosine | |
| 8IC7 | 8IC7 | exo-beta-D-arabinofuranosidase ExoMA2 from Microbacterium arabinogalactanolyticum in complex with beta-D-arabinofuranose | |
| 8IC1 | 8IC1 | endo-alpha-D-arabinanase EndoMA1 D51N mutant from Microbacterium arabinogalactanolyticum in complex with arabinooligosaccharides | |
| 8IBT | B7GUD7 | Crystal structure of GH42 beta-galactosidase BiBga42A from Bifidobacterium longum subspecies infantis E318S mutant in complex with lacto-N-tetraose | |
| 8IBS | B7GUD7 | Crystal structure of GH42 beta-galactosidase BiBga42A from Bifidobacterium longum subspecies infantis E160A/E318A mutant in complex with galactose | |
| 8IBK | A0A2Z5WH92 | Crystal structure of Bacillus sp. AHU2216 GH13_31 Alpha-glucosidase E256Q/N258G in complex with maltotriose | |
| 8IBI | 8IBI | Inactive mutant of CtPL-H210S/F214I | |
| 8IAX | Q8DQ84 | Crystal structure of Streptococcus pneumoniae pyruvate kinase in complex with phosphoenolpyruvate and fructose 1,6-bisphosphate | |
| 8IAV | Q8DQ84 | Crystal structure of Streptococcus pneumoniae pyruvate kinase in complex with fructose 1,6-bisphosphate | |
| 8IAU | Q8DQ84 | Crystal structure of Streptococcus pneumoniae pyruvate kinase in complex with oxalate and fructose 1,6-bisphosphate | |
| 8IAN | 8IAN | Crystal structure of CtPL-H210S/F214I mutant | |
| 8I9H | Q9BYF1 | S-RBD (Omicron XBB.1) in complex with PD of ACE2 | |
| 8I9H | P0DTC2 | S-RBD (Omicron XBB.1) in complex with PD of ACE2 | |
| 8I9G | P0DTC2 | S-RBD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9G | Q9BYF1 | S-RBD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9F | Q9BYF1 | S-RBD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9F | P0DTC2 | S-RBD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9E | Q9BYF1 | S-RBD(Omicron BA.3) in complex with PD of ACE2 | |
| 8I9E | P0DTC2 | S-RBD(Omicron BA.3) in complex with PD of ACE2 | |
| 8I9D | P0DTC2 | S-ECD (Omicron XBB.1) in complex with PD of ACE2 | |
| 8I9D | Q9BYF1 | S-ECD (Omicron XBB.1) in complex with PD of ACE2 | |
| 8I9C | P0DTC2 | S-ECD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9C | Q9BYF1 | S-ECD (Omicron BF.7) in complex with PD of ACE2 | |
| 8I9B | P0DTC2 | S-ECD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I9B | Q9BYF1 | S-ECD (Omicron BA.2.75) in complex with PD of ACE2 | |
| 8I93 | Q9BYF1 | ACE2-B0AT1 complex bound with methionine | |
| 8I93 | Q695T7 | ACE2-B0AT1 complex bound with methionine | |
| 8I92 | Q9BYF1 | ACE2-B0AT1 complex bound with glutamine | |
| 8I92 | Q695T7 | ACE2-B0AT1 complex bound with glutamine | |
| 8I91 | Q9BYF1 | ACE2-SIT1 complex bound with proline | |
| 8I91 | Q9NP91 | ACE2-SIT1 complex bound with proline | |
| 8I5Y | Q15858 | Structure of human Nav1.7 in complex with vixotrigine | |
| 8I5Y | Q07699 | Structure of human Nav1.7 in complex with vixotrigine |
